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Abstract
The regulation of gene expression in response to stress is an essential cellular protection 
mechanism. Recent advances in tRNA modification analysis and genome-based codon bias 
analytics have facilitated studies that lead to a novel model for translational control, with 
translation elongation dynamically regulated during stress responses. Stress-induced increases in 
specific anticodon wobble bases are required for the optimal translation of stress response 
transcripts that are significantly biased in the use of degenerate codons keyed to these modified 
tRNA bases. These findings led us to introduce the notion of tRNA modification tunable 
transcripts (MoTTs – transcripts whose translation is regulated by tRNA modifications), which are 
identifiable using genome-wide codon counting algorithms. In support of this general model of 
translational control of stress response, studies making use of detailed measures of translation, 
tRNA methyltransferase mutants, and computational and mass spectrometry approaches reveal 
that stress reprograms tRNA modifications to translationally regulate MoTTs linked to arginine 
and leucine codons, which helps cells survive insults by damaging agents. These studies highlight 
how tRNA methyltransferase activities and MoTTs are key components of the cellular stress 
response.
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INTRODUCTION
Cellular responses to stress and damage
Damage, stress and disease—The chemical nature of DNA, protein and lipids makes 
these vital cellular macromolecules susceptible to damage from endogenous and exogenous 
agents. Normal metabolic processes can produce alkylating agents (i.e., formaldehyde and 
nitrosamines) and a wide array of reactive oxygen and reactive nitrogen species (i.e., OH, 
H2O2 and NO) [1]. Similarly, environmental exposures to pesticides, consumer products and 
radiation sources can also promote cellular alkylation, oxidation and nitrosation damage. 
Alkylating and oxidizing agents have the potential to disrupt the cellular redox balance by 
depleting cellular glutathione levels and can damage DNA, proteins and lipids [2–4]. DNA 
damage can drive mutagenesis and the resulting DNA sequence changes can drive 
carcinogenesis and cancer progression. Protein damage can deplete the cell of vital 
activities, cause protein aggregation and result in the formation of reactive carbonyls (i.e., 
advanced glycation end products), with the latter two mechanisms implicated in 
neurodegenerative diseases [5]. Lipid damage in the form of peroxidation can generate 
DNA- and protein-damaging agents, as well as disrupt cellular membranes. Lipid damage is 
linked to both cancer and neurodegenerative disease [5]. Lastly, disruption of cellular redox 
balance can promote inflammation, with this being linked to a host of chronic diseases [6–
8]. Cells respond to all of these stresses by controlling expression of a variety of response 
genes, including the DNA damage response.
DNA damage response—The DNA base and sugar moieties are subject to damage by 
oxidation and alkylation that generate adducts and cause single- and double-strand breaks 
[1]. All types of cells, ranging from simple prokaryotes and eukaryotes to mammals, have 
built in defense mechanisms to respond to chemical and physical changes to the genome in 
the form of the DNA damage response. For example, DNA double-strand breaks are 
recognized by sensor proteins, which in turn recruit transducer proteins to activate a cascade 
of signals. The activated DNA damage response will regulate the cell cycle, increase the 
level of DNA repair proteins and in some cases signal for cell death [9, 10]. In humans, the 
sensor, transducer and DNA repair proteins can include MRN complex (Mre11-Rad51-
Nbs1), ATM, p53 and Brca1, to name a few, with disruptions leading to genome instability 
syndromes and increased cancer incidence [11–13]. Single-strand breaks, specific 
mismatches and bulky DNA adducts will also activate the DNA damage response. The 
signalling cascade linked to the DNA damage response will optimize the cell for DNA 
repair and in most cases maintaining the integrity of the DNA and health of the cell and 
organism [14].
Heat shock and unfolded protein responses—In addition to DNA damage, 
alkylating and oxidizing agents can promote protein damage to activate protein-stress 
response pathways [15–17]. Translation errors and compounds that disrupt post-translational 
processing of proteins can also promote folding problems. The Streptomyces-produced 
nucleoside antibiotic mixture Tunicamycin is a compound that prevents N-linked 
glycosylation [18]. Misfolded and unfolded proteins are readily recognized by cellular 
machinery and activate the cytoplasmic heat shock response (HSR) and endoplasmic 
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reticulum (ER)-associated unfolded protein response (UPR) [19]. Both HSR and UPR 
activate chaperone and signal transduction systems to refold proteins and in some cases 
reprogram the cell. For example, the UPR will recognize misfolded proteins in the ER 
lumen using a chaperone protein. The activated UPR turns on an elegant signal transduction 
pathway that includes splicing of a specific mRNA (i.e., HAC1 in budding yeast) to promote 
the production of an active transcription factor and up-regulation of systems to promote 
folding and, if prolonged, promote cell death [20, 21]. Tunicamycin components are classic 
activators of the UPR [22]. An overactive UPR is implicated in the pathogenesis of cancer 
and amyotrophic lateral sclerosis, Parkinson’s, Huntington’s and Alzheimer’s diseases [23].
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) response 
and detoxification—ROS can include O2• and H2O2 from the mitochondria and OH• 
from Fenton reduction of H2O2 and breakdown of reactive nitrogen species such as 
peroxynitrite (ONOO−) [1]. ROS and RNS can damage all types of biomolecules, including 
RNA, lipids, proteins and carbohydrates, with damage and response best characterized for 
DNA. Increased O2• and H2O2 levels inside the cell will promote the oxidation of protein-
based cysteine amino acids. The AP-1 like transcription factors have harnessed oxidized 
cysteine to sense fluxes in cellular ROS levels and activate detoxification systems [3, 24]. 
Superoxide dismutase can detoxify O2• to produce H2O2, which is further detoxified by 
catalase and glutathione peroxidase (Gpx) enzymes to make H2O [3, 25]. Gpx proteins 
require reduced glutathione as a cofactor to detoxify H2O2 and have also been shown to 
work on peroxidized lipids [26, 27], with many of the Gpx enzymes possessing the amino 
acid selenocysteine (Sec) as a key catalytic residue.
Targeted changes in gene expression are the key to an appropriate and efficient response to 
DNA or protein damage or increased ROS and RNS levels. Gene expression can be 
regulated at many different levels in eukaryotic systems, including transcription, translation 
and post-translational mechanisms. In this review, we will focus on translational control 
mechanisms. Specifically we will focus on how tRNA modification enzymes regulate the 
translation of key stress response proteins. In addition we will discuss how tRNA 
modification defects lead to protein errors, with the latter phenotypes potentially exploitable 
for disease treatments.
tRNA modifications
tRNA structure and function—With their 3′-linked amino acids, tRNA molecules are 
composed of 70–90 nucleotides of linear sequence that folds into a cloverleaf-shaped 
secondary structure and L-shaped tertiary structure, which fits into the tRNA binding sites 
(P and A) in the ribosome. They are initially transcribed with canonical U, A, C and G 
bases, but the nucleobases and ribose sugars are chemical modified by a large system of 
enzymes to form one of >120 different known chemical structures. There are ~25–30 types 
of modified ribonucleosides in an organism and an average of 11 and 13 modifications 
spread throughout each tRNA in yeast and humans, respectively [28–32]. As shown in 
Figure 1 for budding yeast, the structures of these modifications on tRNA are highly diverse, 
ranging in complexity from simple methylation to amino acid conjugation to multi-step 
biosynthetic reactions leading to complex ring structures [33, 34]. To a certain extent there 
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are conserved locations for many of these modifications, such as the presence of 
dihydrouridine (D) and pseudouridine (ψ) in the D stem and loop and T stem and loop of 
many tRNAs, respectively. There are also a large number of chemically distinct 
modifications found in the anticodon stem and loop [35]. Interestingly, although these non-
canonical nucleosides can be located throughout the structure of tRNA, the significance of 
their functions remains elusive. It was initially believed that these modified ribonucleosides 
played mainly structural roles by stabilizing the unique secondary and tertiary structures of 
tRNA. For example, the highly conserved D imparts flexibility [36], whereas ψ and 2′-O-
methylation stabilize base stacking [33, 34, 37]. More importantly, the large diversity of 
chemical structures in the anticodon loop, and especially at the wobble position, has been 
shown to be critical for translational fidelity, frame-shift prevention and translation 
efficiency [33, 34, 38–40]. We recently expanded these roles for wobble modifications to 
include fine-tuning of the efficiency of translation of codon-biased mRNAs from classes of 
stress response genes [41–45]. The clear regulatory function of tRNA modifications thus 
raises the issue of pathology and disease caused by defects in tRNA function.
Chemistry of modification in anticodon stem and loop and its link to 
translational control—The diversity of tRNA modification structures, the fact that some 
wobble base modifications are only found on a subset of tRNAs that interact with select 
codons and the known role of wobble modifications in modulating anticodon-codon 
interactions, all suggest a role for anticodon stem and loop tRNA modifications in regulating 
translation by virtue of their ability to control the rate of translational elongation [33, 34]. 
Indeed, if they play a regulatory role, tRNA modifications must change in response to 
specific alterations in cell state. In addition the changes must alter the codon-reading 
properties of the associated tRNA. The variety of chemical structures at wobble positions 
supports this model. In budding yeast, 9 of the 24 modified ribonucleosides (Figure 1) are 
found at the wobble position 34 in tRNA [46]: ψ, hypoxanthine (I), 2′-O-methylguanosine 
(Gm), 2′-O-methylcytidine (Cm), 5-methoxycarbonylmethyluridine (mcm5U), 5-
methoxycarbonylmethyl-2-thiouridine (mcm5s2U), 5-carbamoylmethyluridine (ncm5U) and 
5-carbamoylmethyl-2′-O-methyluridine (ncm5Um). It is important to note that the majority 
of these wobble modifications occur at U, which gives this pyrimidine significant regulatory 
flexibility in reading a codon. For example, yeast tRNA methyltransferase 9 (Trm9) 
participates in the biosynthesis of mcm5s2U and mcm5U by adding the final methyl group at 
wobble positions in five tRNA species (tRNAArg(UCU), tRNAGly(UCC), tRNALys(UUU), 
tRNAGln(UUG) and tRNAGlu(UUC)) [47, 48]. It has been shown that tRNAArg(UCU) plays a 
central role in the response to alkylating agents, with enhanced translation of mRNAs 
containing its cognate AGA codon [45]. Another feature of wobble modifications is their 
frequent tRNA specificity. For example, tRNA methyltransferase 4 (Trm4) catalyzes the 
formation of m5C in over 34 species of tRNA, most frequently at position 48 between the 
variable arm and T stem loop [32]. However, tRNALeu(CAA) is the only tRNA with m5C at 
the wobble position [32] and we have shown that this uniqueness plays a role in the 
regulation of translation during the oxidative stress response [42]. The role of wobble base 
methylation of pyrimidine nucleobase structures thus emerges as a central feature of a 
tRNA-based translation regulatory system.
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tRNA methyltransferases
General reaction mechanism—tRNA methyltransferases (Trm) transfer the methyl 
group from S-adenosyl methionine (SAM) to the 2′-OH of the ribose sugar, to the carbon 
and nitrogen atoms of the nucleobase, or to nucleophilic sites in modification intermediates 
(some examples are shown in Figure 2). There are 18 known Trm enzymes in S. cerevisiae, 
with genomic analyses predicting 36 human Trms [49]. In many cases, and for both Trm4 
and Trm9, there are 2 or more human homologs for each yeast Trm, which suggests 
diversification or specialization of Trm activity to new modifications in humans, 
modification of different tRNAs or RNA substrates, or functions other than tRNA 
modification. Such is the case for the human Trm9 homologs, ALKBH8 and hTRM9L. 
There is also a diversity of function among Trms, with ALKBH8 homologs in mammalian, 
bacterial and protozoan cells showing DNA dealkylation repair activity and RNA oxidation 
activity, both derived from the Fe(II) and 2-oxoglutarate-dependent oxygenase domain of 
the protein [50]. Mammalian and plant ALKBH8 homologs are tRNA hydroxylases that 
convert mcm5U to (S)-5-methoxycarbonylhydroxymethyluridine (mchm5U) at the wobble 
position of tRNAGly(UCC) [51, 52]. At the same time, ALKBH8 also catalyzes methylation 
of wobble U derivatives to form mcm5U and mcm5s2U in certain tRNA species, such as the 
tRNA for Sec [51, 53–55]. Regardless of enzyme identity or regulation, modified 
ribonucleosides can promote tRNA structural stability and folding, translational fidelity, 
frame-shift prevention and translation efficiency, with evidence for roles in tRNA quality 
control, cellular stress responses and cell growth [34, 38–40, 46, 56, 57].
Human tRNA modification systems and disease—Akin to the emerging recognition 
of defects in tRNA aminoacyl synthases in a variety of human diseases [58], several clinical 
observations point to critical roles for tRNA modifications in human diseases such as 
cancer. This point is illustrated with ALKBH8 and hTRM9L human homologs of yeast 
Trm9 [51, 53, 54]. ALKBH8 has been shown to be over-expressed in human bladder cancers 
and thought to be anti-apoptotic, as silencing its expression down-regulated NOX-1 activity 
and caused activation of the JNK and p38 pathway, leading to increased apoptosis [53]. Its 
homologous partner, hTRM9L, on the other hand, appears to be epigenetically silenced in 
breast, testicular, bladder and colon cancers [59]. Indeed, re-expression of hTRM9L in 
SW620 and HCT116 colorectal cancer cell lines, in which hTRM9L is silenced, suppresses 
tumor growth and promotes senescence [59]. We also note that hTRM9L maps to the short 
arm of chromosome 8, a region commonly lost or silenced in many cancers, including 
colorectal and breast [60–64]. Available data suggest a model in which ALKBH8 and 
hTRM9L have opposing roles in managing cell survival and cell death. For example, 
ALKBH8 has been shown to be vital for cell viability in late stage tumors, with knockdown 
leading to cell death [53]. Similarly, turning off hTRM9L in late stage tumors is required for 
them to grow, [59, 64, 65] as re-expression of TRM9L in late-stage models drives these cells 
into senescence [59].
Yeast tRNA modification systems and associated phenotypes—Biochemical 
characterization of tRNA modification systems in E. coli and S. cerevisiae has led to the 
identification of many of the proteins and synthetic steps needed to generate specific tRNA 
modifications. The creation and systematic use of a library of S. cerevisiae gene deletion 
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mutants have also allowed researchers to observe the association between tRNA 
modification deficient cells (i.e., trmΔ) and stress phenotypes (examples in Figure 2). 
Deletion of a specific tRNA modification system can lead to global or specific hypo-
modification of tRNA. Hypo-modification of tRNA is linked to disease pathology in 
humans, with specific under-modification of yeast tRNA leading to sensitivity to agents that 
promote increased ROS, DNA damage and protein errors. For example, trm4Δ cells are 
sensitive to killing by H2O2, suggesting that they have a compromised response to ROS-
inducing agents, which could be due to decreased translation of a critical detoxification 
protein (Figure 2) [42]. Sensitivity to agents that promote DNA double-strand breaks and S-
phase damage (IR, MMS and HU) have been demonstrated for trm9Δ cells, which could be 
due to a defect in the translation of critical DNA replication activity [44, 66]. In support of 
this translation defect idea, trm9Δ cells demonstrate sensitivity to aminoglycoside antibiotics 
that promote protein synthesis errors, with the cells revealing increases in arginine for serine 
misincorporation events and frame-shifting [66]. The aminoglycoside-induced sensitivity 
and increased translational errors in trm9Δ cells promote protein errors and misfolding, with 
the absence of Trm9 leading to activation of the UPR and HSR (Figure 2). Notably tRNA 
modification deficient strains have reported phenotypes that include slow growth and 
sensitivity to 5-fluorouracil, ultraviolet radiation, cycloheximide and heat, with each 
phenotype potentially due to defects in stress signalling and/or protein synthesis [67, 68, 69 
70].
The connection between stress phenotypes, hypo-modification of tRNA, and protein 
synthesis defects in trm mutants supports the idea that there may be a distinct translational 
response to stress. To help decipher the translational responses, new technologies and 
analytic approaches have been developed. Coming in the form of mass spectrometry-based 
ribonucleoside analysis and genome-wide codon bias analytics, these approaches have 
helped link tRNA modifications to the regulation of critical stress response proteins. 
Systems-based approaches reveal that groups of codon-biased transcripts over-use codons 
that can be linked to specific tRNA modifications, with subsequently translated proteins also 
functioning in stress response pathways. Together, these results support the idea that many 
stress response proteins are translated from tRNA modification tunable transcripts (MoTTs), 
a concept discussed in detail below.
Methyl-based modifications regulate gene expression
Transcriptional regulation by m5C—We have observed a critical role for tRNA 
modifications, and tRNA methylation in particular, in the control of translation following 
stress. A common theme associated with the control of gene expression, and in some cases 
epigenetics, is the use of enzyme-catalyzed methylation to regulate transcription, with the 
corresponding epigenetic marks regulated or dramatically altered in response to 
environmental stimuli or in different cancers. For example, enzyme-catalyzed methylation 
by DNA methyltransferases (DNMT’s) to form m5C is a well-established regulator of gene 
transcription [71–74], with methylation patterns in some promoter regions reprogrammed by 
stress or altered in some cancers [75, 76]. Promoter CpG methylation can silence the 
transcription of tumor suppressor activities leading to decreased DNA damage signaling and 
DNA repair, thus contributing to the etiology of different cancers [76]. Histone methylation 
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by protein methyltransferases (PMT’s) functions in a similar manner as a well-recognized 
regulator of gene expression, with the “epigenetic” methylation marks occurring on histone 
tails [77]. As part of an integrated system with DNA methylation, histone methylation is 
theorized to be part of a complicated “histone code” that is altered by environmental signals 
and disease pathologies to control gene expression. Lysine N7-methylation (H3K4, H3K36) 
in histone H3 and the subsequent demethylation are considered to be dueling signals that 
regulate transcription. At their simplest, both promoter and histone methylation affect gene 
expression by regulating how much of a transcript is made, with these epigenetic signals 
altered in cancer to drive pathogenesis and reprogrammed after environmental exposures. 
However, the simplicity of methylation as the sole chemistry of epigenetic marks has now 
been complicated by the emergence of 5-hydroxylmethylcytidine, 5-formylcytidine and 5-
carboxycytidine as putative epigenetic marks in DNA [78].
tRNA methylation and translational regulation—In parallel with DNA and histone 
protein methylation, we introduce the concept of RNA modifications, including RNA 
methylation, as marks that reprogram in response to environmental changes and control gene 
expression at the level of translation. We and others have demonstrated that tRNA 
modification enzymes and their homologs are tumor growth suppressors and down-regulated 
in some cancers [59] [64, 79]. We have also observed that tRNA methylation affects gene 
expression by regulating how well a transcript is translated [41–45, 66]. The DNA and RNA 
modification activities represented by DNMTs, PMTs and Trms share a common theme of 
regulating gene expression by enzyme-catalyzed methylation, with altered regulation/
patterns linked to environmental exposure and cancer. The concept of tRNA wobble 
methylation expands methylation signals to regulators of translation and links tRNA 
modifications and Trms to the synthesis of proteins vital to stress responses [41–45, 66]. A 
major problem with studying RNA modification signals is the availability of technology to 
analyze and quantify them, which we have solved by developing a novel bioanalytical and 
bioinformatic platform.
Stress-induced changes in tRNA modification levels are linked to MoTTs
Quantifying changes in tRNA modification levels: A mass spectrometry and 
bioinformatic platform for identifying and quantifying modified 
ribonucleosides—The model we have developed posits tRNA modifications as 
regulatory elements, which requires that they be coordinately regulated and dynamically 
altered in response to a stimulus. Following on our initial observations linking tRNA wobble 
mcm5U and selective translation of codon-biased mRNAs in response to alkylation stress 
[45], we undertook an assessment of stress-induced changes in the full set of 24 tRNA 
modifications in budding yeast, with the goal of identifying patterns and behaviors for 
different stresses. To facilitate this systems-level analysis, we developed a chromatography-
coupled mass spectrometry (LC-MS) platform [80] that entails (1) RNA isolation and HPLC 
purification of tRNA [81], (2) enzymatic hydrolysis to ribonucleosides for reversed-phase 
HPLC resolution, (3) mass spectrometry-based identification and quantification of 
individual ribonucleosides and (4) multivariate statistical analysis of the resulting fold-
change data comparing controls to treatment conditions (Figure 1) [41, 42, 80]. We then 
used this platform to analyze changes in the levels of tRNA modifications after exposing 
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yeast to equitoxic doses of four mechanistically distinct toxicants: H2O2, MMS, sodium 
arsenite (NaAsO2) and sodium hypochlorite (NaOCl). As we reported [41], the levels of 23 
tRNA modifications uniquely changed in response to each toxicant, with hierarchical 
clustering of fold-change data distinguishing both agent and dose as signature patterns of 
increase and decrease. These stress-specific patterns of tRNA modification changes were 
then linked to selective translation of codon-biased mRNAs for stress response proteins [42], 
which raises the concept of MoTTs.
MoTTs: Codon specific regulation of translation—Changes in wobble base tRNA 
modification levels have the potential to work in concert with codon usage patterns in 
specific transcripts to regulate translation of response proteins. These can be designated as 
modification tunable transcripts (MoTTs), with Figure 3 detailing the methodology used to 
identify MoTTs in any organism [43]. The concept of MoTTs is similar to the idea in 
mammals that the transcription of some but not all genes can be regulated by promoter 
methylation (m5C) and is analogous to transcripts specific to enzymes containing Sec, a 
non-standard amino acid with a tRNA that reads internal stop codons, as discussed in the 
next section. The idea is that the MoTTs preferentially use one of several degenerate codons 
for an amino acid. In order to identify MoTTs and evaluate the use of specific codons and 
codon combinations in genes and gene networks, we developed a gene-specific codon 
counting (GSCC) algorithm as a codon usage and statistical analysis tool. Further we 
employed the GSCC algorithm to analyze the 5,780 genes in S. cerevisiae [82]. 
Visualization approaches were then used to identify distinct codon usage patterns in specific 
genes and groups of genes. A computational analysis of S. cerevisiae cDNAs revealed 425 
open reading frames that possess statistically significant deviations in the usage of 29 
codons compared to other transcripts [45, 82]. This over-usage includes the presence of 
many non-preferred (i.e., non-optimal) codons, relative to genome averages. The 425 codon-
biased transcripts represent potential MoTTs and they over- or under-use specific mono-
codons throughout their open reading frames. Interestingly, several quad-codon patterns 
(i.e., 4 repeats of a codon) are well represented in the 425 identified transcripts. Many of the 
MoTTs-associated codons are found in mixed codon boxes in which wobble base tRNA 
modifications enhance interactions with one codon (i.e., AGA for Arg) while restricting 
interactions with others (i.e., AGC for Ser). Functional analysis of the 425 potential MoTTs 
found that their corresponding proteins are over-represented in activities associated with 
protein synthesis, metabolism and stress responses, with four prominent members of the 
DNA damage response (RNR1-4) identified. As described in detail shortly, several published 
studies support the idea that translation of specific codon-biased transcripts can be regulated 
by tRNA modifications, with stress response genes well represented in our list of candidate 
MoTTs. This concept of codon usage, tRNA modification reprogramming and selective 
translation is illustrated by stop-codon recoding for mRNAs of Sec-containing proteins.
Alkylation damage and mcm5U—One example of the connection between the 
modification status at a tRNA wobble position and cellular stress response is showcased in 
our report that the presence of mcm5U at the wobble position of certain tRNA was crucial 
for cell survival following DNA alkylation damage [45]. In S. cerevisiae, TRM9 catalyzes 
the addition of the final methyl group on the modifications mcm5U and mcm5s2U, which are 
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found at the uridine wobble base of tRNAARG(UCU) and tRNAGLU(UUC). The mRNAs for 
yeast translation elongation factor 3 (YEF3) and ribonucleotide reductases 1 (RNR1) and 3 
(RNR3) are over-represented with AGA and GAA codons. YEF3, RNR1 and RNR3 fit the 
criteria for MoTTs because they over-use specific degenerate codons and the last two 
correspond to established stress response activities. The basal translation of YEF3, RNR1 
and RNR3 mRNA was found to be dramatically decreased in trm9Δ cells lacking mcm5U 
and mcm5s2U in the corresponding tRNA anticodons [45]. The decrease in the tRNA 
modifications led to reduced expression of these key damage response proteins even though 
the transcription of these genes remained unperturbed, and ultimately caused enhanced 
susceptibility of trm9Δ cells to DNA alkylation agents [45].
Oxidative damage and m5C—Previously, we showed that the S. cerevisiae Trm4-
catalyzed modification of C to m5C at the wobble position of tRNALeu(CAA) increased in 
response H2O2 exposure, which stimulated translation of mRNAs (MoTTs) derived from the 
38 genes in yeast in which 90% or more of the leucines are encoded by UUG [42]. Among 
these UUG-enriched MoTTs is that for the ribosomal protein Rpl22a, one of two alternative 
proteins for Rpl22, which, in terms of mRNA sequence, stands in sharp contrast with the 
mRNA for its paralog Rpl22b that lacks significant enrichment of UUG, despite apparent 
homology at the amino acid level. As expected, H2O2 exposure did not increase the rate of 
translation of Rpl22b, a non-MoTT, and only deletion of the gene for Rpl22a, a MoTT, 
rendered the cells sensitive to killing by H2O2-induced oxidative stress [42]. These results 
provide a direct link between stress-induced increases in a specific wobble tRNA 
modification and enhanced translation of codon-biased mRNAs for critical stress response 
genes. This again illustrates the concept of MoTTs. Notably, mRNA levels for RPL22A, 
YEF3, RNR1 and RNR3 are identical in wild-type, trm4Δ (for RPL22A) and trm9Δ (for 
YEF3, RNR1, and RNR3) cells [42, 45], which further demonstrates that the tRNA 
modification-dependent gene regulation program operates at the level of translation.
Stop-codon recoding as a well-studied example of MoTTs—The connection 
between tRNA modifications and stress response enzymes has previously been described 
during the process of translational recoding. Sec is considered the 21st amino acid and a 
dedicated codon for this amino acid is not found in the genetic code. To accommodate 
incorporation of this non-standard amino acid, some organisms, including mice and humans, 
use an internal stop codon (UGA) and specific sequences in the 3′ untranslated region 
(UTR) of the mRNA to signal for Sec incorporation. Sec is the key active site amino acid in 
some Gpxs and thioredoxin reductases (TrxRs). Many selenoproteins are regulated by 
selenium levels and have stress response roles specific to the detoxification of ROS [83–84]. 
Sec is charged on specific tRNAs that contain anticodons that pair with the UGA stop 
codon, tRNASec(UCA), and the enzyme-catalyzed tRNA modifications mcm5U and mcm5Um 
are found at the wobble position. The modifications 1-methyladenosine (m1A) at position 
58, ψ at position 55, and isopentenyladenosine (i6A) at position 37 are also found on 
tRNASec(UCA) [85]. The presence of m1A, ψ, i6A and mcm5U is required for the formation 
of mcm5Um, with the levels of this modification being sensitive to selenium concentration 
inside the cell and promoting a distinct tertiary structure [86]. The two different states for 
tRNASec(UGA) suggest a highly regulated modification pattern and support the translation of 
Gu et al. Page 9
FEBS Lett. Author manuscript; available in PMC 2015 November 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
distinct subclasses of selenoproteins. Elegant studies in mice have demonstrated that mcm5U 
and mcm5Um are required for efficient incorporation of Sec into specific selenoproteins [54, 
87]. There are 25 selenoproteins in humans, as identified by computational approaches that 
identify internal stop codons and regulatory sequences [88]. From the perspective of codon 
usage, transcripts corresponding to selenoproteins are severely biased as they contain more 
than one stop codon, which is significant compared to the thousands of transcripts in humans 
that use standard amino acids and contain only a single stop codon. The concept of codon 
bias being used to regulate the translation of stress response proteins is an exciting prospect, 
and we put forth the Sec transcripts are MoTTs.
Regulation of translation elongation
Model for increased translation by anticodon loop modifications—Studies on 
mcm5U and m5C support a general model (Figure 4) in which translation elongation is 
regulated to promote cellular stress responses. The ability to change the kinetic and 
thermodynamic properties of specific anticodon-codon interactions is linked to wobble base 
tRNA modifications, making them ideal regulatory points. Stress-induced increases in 
mcm5U and m5C (or any wobble modification) allow for increased decoding of specific 
codons, which can be regulatory in MoTTs that over-use the codon. The increased 
modification of tRNA selectively increases the translation of MoTTs, which can, in effect, 
accelerate the translation of specific transcripts and lead to increased levels of critical 
response proteins. The increased tRNA modification also has the potential to increase 
translational fidelity, which should correspond to more active proteins. Such decreased 
protein errors would allow the cell to repurpose protein stress response systems during times 
of increased external stimuli. Our model is supported by (1) codon reporter systems and 
studies that support idea that specific codons need specific tRNA modifications to be 
efficiently translated; (2) the observation of increased wobble base modifications under 
specific stressors; (3) polysome profiles that demonstrate altered distribution of codon-
biased transcripts in trm mutants; (4) matched mRNA and protein studies that show 
decreased levels of critical stress response proteins in trm mutants and (5) the observation 
that specific tRNA modifications promote translational fidelity [41–45, 66, 84, 89, 90]
Potential for tRNA modifications to restrict translation—The other side of 
translational regulation is the potential to down-regulate translation of specific proteins in 
response to environmental changes. This idea is illustrated in our codon reporter assays in 
budding yeast, which demonstrate that GAG-GAG-GAG-GAG is translated at higher levels 
in trm9Δ cells relative to wild-type cells [44]. This suggests that mcm5s2U tRNA 
modifications, which are found in tRNAGlu that decodes GAG, can repress translation of 
mRNAs that contain specific codon sequences. We have used our Gene-Specific Codon 
Counting database to identify 8 genes containing at ≥1 GAG-GAG-GAG-GAG sequence 
[82]. Functional analysis of these proteins indicates that many are involved in ribosomal 
RNA regulation and vesicle function.
Exploiting tRNA modifications for disease treatment
Cancer therapeutics—Carcinogenesis and cancer progression can be attributed to many 
different endogenous and environmental agents that promote damage, cell stress or alter 
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physiological conditions that promote cell growth. As described above, tRNA modification 
systems specific to the anticodon loop of key tRNAs regulate cellular stress responses and 
can promote the detoxification of damaging agents and efficient DNA repair to prevent cell 
death. Regulating responses to stress is a classic role for tumor suppressor proteins, with p53 
as the archetype. Defects in p53 can corrupt cellular responses to DNA damaging agents, by 
preventing activation of downstream components and cell cycle checkpoints. p53-
inactivating mutations are reported for many cancers and can allow for increased 
proliferation of cancer cells [91–93]. Decreased expression of known and potential tRNA 
modification enzymes have also been reported in lung and colorectal cancers. The tRNA-
isopentenyltransferase (tRNA-IPT) TRIT1 is responsible for the formation of i6A and the 
modification is found at position 37 of many tRNAs, most notably tRNASec. TRIT1 levels 
are decreased in lung adenocarcinomas [79], which could compromise stress responses and 
give TRIT1 a growth suppressive role in some lung cancers. The human hTRM9L homolog 
of yeast Trm9 has been identified as a tumor growth suppressor in colorectal cancers, with 
deficiencies in hTRM9L found in specific cell models (SW620, HCT116, LoVo) and 
colorectal tumors from the clinic. The tumor growth suppressor role of hTRM9L suggests 
that it could be involved in stress response regulation, with this under investigation. Based 
on data generated in bacterial, yeast and mammalian cell culture models, deficiencies in 
specific tRNA modification enzymes and tRNA modifications should sensitize cancer cells 
to particular therapeutics. For example, he tRNA-IPT activity is required for modification of 
tRNASec. Knockdown of tRNA-IPT or failure to modify A37 leads to decreased 
selenoprotein levels [94], with ROS detoxifying enzymes as notable members. These data 
suggest that TRIT1-deficient lung tumors would be sensitized to therapeutics that promote 
increased ROS. Similarly, a deficiency in hTRM9L has been shown to sensitize colorectal 
cancer cells to killing by aminoglycoside antibiotics [59]. The US Food and Drug 
Administration has already approved aminoglycoside antibiotics for Gram-negative, select 
Gram-positive and protozoal infections. Together with the cell-based killing data, this 
existing clinical use makes aminoglycoside drugs like paromomycin and gentamicin 
attractive personalized medical therapeutics for colorectal cancer.
Antibiotics—tRNA modification enzymes may also serve as potential targets for anti-
fungal and antibiotic development, as they are already used by competing organisms to kill 
other species. For example, the mcm5s2U modification of S. cerevisiae is targeted by killer 
toxin system of K. lactus, with the associated endoribonuclease cleaving the ASL of specific 
tRNAs to shut down translation in S. cerevisiae [95, 96]. A potential drug-able example is 
found for TrmD, which is a tRNA methyltransferase that methylates a guanine at position 37 
of various bacterial tRNAs [97–100]. The gene for TrmD is essential in many types of 
bacteria [98, 99], which points to its potential as an antibiotic target. In addition humans use 
a different family of Mtase enzymes to methylate guanine at position 37, which supports the 
idea that any drugs that target TrmD would be specific to bacteria. Several groups have 
explored the development of inhibitors of SAM binding to TrmD, with identification of 
several SAM analogs that bind with relatively high affinity [101, 102]. In one case, fused 
thieno-pyrimidones were identified as competitive inhibitors of SAM binding, with 
nanomolar binding affinity and a lack of activity against human homologs of TrmD [102].
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Conclusions and Perspectives
In conclusion, we have described the technology and studies that support the idea that 
dynamic tRNA modifications regulate the translation of codon-biased transcripts. The 
unique reprogramming of tRNA modifications observed after cells were treated with DNA-
damaging or ROS-inducing agents will most likely be a conserved theme for responses to 
other distinct stressors. For example, nutritional stress is predicted to promote 
reprogramming of tRNA modifications to drive a translational response program, which 
could also be coupled to tRNA degradation and altered aminoacylation programs. We have 
made the case that tRNA modification reprogramming is tightly linked to MoTTs, with 
these distinct transcripts serving as blue prints for translation. While we describe MoTTs as 
having codon biases that signal for “on” or more translation, there exists a strong possibility 
that specific tRNA modification patterns can be used to signal for “off” and slow down 
translation of specific transcripts. Turning off stress responses is an important and 
understudied area, but from the perspective of the cell, efficient down-regulation of cellular 
programs (i.e., DNA replication) can help protect against offending agents. There are 
established and exploitable connections between tRNA modification systems and disease. 
We envision personalized cancer therapeutics that target specific modification programs, 
with the tRNA modification signature giving cancers cells a growth advantage but making 
them susceptible to a specific stressor. Aminoglycoside antibiotics are potential route 
towards realizing this potential, but further study and pharmacological optimizations are 
needed. Similarly the targeting of organism specific tRNA modification systems also has 
great potential for treating infectious agents, as pathogen specific Trms and their unique 
chemically modified tRNAs are attractive targets.
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Figure 1. Stress-induced changes in tRNA modification as measured by LC-MS/MS
Budding yeast contain 25 modified ribonucleosides, of which 23 can be measured by 
chromatography-coupled tandem mass spectrometry (LC-MS/MS). Following tRNA 
isolation and hydrolysis, individual modified ribonucleosides are resolved by reversed-phase 
HPLC and quantified by tandem mass spectrometry. The data are used to calculate fold-
change values comparing control cells to stressed cells, with the fold-change values 
analyzed by multivariate statistics to identify patterns of stress-induced changes. The heat 
map represents fold-change data for four mechanistically distinct toxicants and shows both 
agent- and dose-specific signatures. The heat map image was reproduced from Chan et al. 
(2010) PLoS Genetics 6: e1001247.
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Figure 2. tRNA modifications and their relation to stress signaling pathways
Description of mutant phenotypes for cells deficient in Trm9 and Trm4, structure of 
substrates and products for each enzyme catalyzed tRNA modification, the pathways 
regulated by each tRNA methyltransferases, and pathways whose activation is prevented 
(underlined) by proper tRNA modification, via the prevention of amino acid 
misincorporation errors.
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Figure 3. Genome-based identification of MoTTs
Iterative analysis of each open reading frame is used to count the number of codons in each 
gene and determine the frequency of use of synonymous codons for each amino acid (Steps 
1 – 3). After analysis of all genes in a genome, the average value for all genes is then used to 
identify specific genes that are over- (yellow) or under- (purple) using a codon, with groups 
of genes that have similar codon over- and under-usage patterns identified by clustering and 
heat map visualization (Step 4).
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Figure 4. Changes in tRNA modification regulate the translation of MoTTs
The scheme depicts the concept of stress-induced tRNA reprogramming and selective 
translation of codon-biased mRNAs (MoTTs) for oxidative stress in budding yeast.
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